Nutriband Inc.
NTRB
Rank in Stocks
#21161
Nutriband Inc. specializes in developing a diverse range of pharmaceutical... Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.
Share Price
$5.96
Last synced: 2026-11-09
Market Cap
$72.45M
Change (1 day)
7.39%
Change (1 year)
-2.13%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nutriband Inc. (NTRB)
Category
Healthcare
Operating Margin for Nutriband Inc. (NTRB)
Operating Margin as of November 2026 TTM: -435.58%
According to Nutriband Inc.'s latest financial reports, its current operating margin (TTM) is -435.58%. At the end of 2025 the company had an operating margin of -312.62%.
Operating Margin history for Nutriband Inc. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -435.58% | 39.33% |
| 2025 | -312.62% | 33.81% |
| 2024 | -233.63% | 17.14% |
| 2023 | -199.45% | -27.82% |
| 2022 | -276.33% | 0.45% |
| 2021 | -275.08% | -48.23% |
| 2020 | -531.35% | -60.88% |
| 2019 | -1,358.11% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.09% |
US
|
|
| -149.01% | -99.66% |
US
|
|
| 25.57% | -100.06% |
AU
|
|
| 31.23% | -100.07% |
BE
|
|
| 29.35% | -100.07% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Nutriband Inc.'s operating margin
What is Nutriband Inc.'s operating margin?
Nutriband Inc.'s operating margin is -435.58%, as of Nov 2026.
What was Nutriband Inc.'s operating margin in 2025?
In 2025, Nutriband Inc.'s operating margin was -312.62%, compared with -233.63% in 2024.
How has Nutriband Inc.'s operating margin changed since 2020?
From 2020 to 2025, Nutriband Inc.'s operating margin was highest in 2023 (-199.45%) and lowest in 2020 (-531.35%).
How does Nutriband Inc.'s operating margin compare with similar companies?
Nutriband Inc.'s operating margin (-435.58%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.